Addex Therapeutics (ADXN) Cash from Discontinued Operations (2023 - 2024)
Addex Therapeutics' (ADXN) quarterly Cash from Discontinued Operations came in at 0.15 in Q2 2024, up 563.99% year-on-year from 0.02 in Q3 2023, and up 100.0% quarter-over-quarter from 2748845.89 in Q1 2024.
Addex Therapeutics (ADXN) Cash from Discontinued Operations (2023 - 2024) Analysis & Trends
Addex Therapeutics has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting 0.15 for Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -59.14 Mn |
| 10 | Addex Therapeutics | 1.23 Bn | 1.23 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.15 |
| Jun 30, 2024 | 0.15 |
| Mar 31, 2024 | -2.75 Mn |
| Mar 31, 2024 | -2.75 Mn |
| Sep 30, 2023 | -0.02 |
| Sep 30, 2023 | -0.02 |
| Jun 30, 2023 | -0.03 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -2.23 Mn |
| Mar 31, 2023 | -2.23 Mn |